DalsnaFinance › IPOs › Zymeworks Inc › IPO
Zymeworks BC Inc. completed its initial public offering on NYSE on April 28, 2017, pricing at $13.00 a share.
| Ticker | ZYME |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | April 28, 2017 |
| Offering price | $13.00 |
| Shares offered | 4,500,000 |
| Total raised | $59M |
Zymeworks BC Inc. sold 4,500,000 shares at $13.00 each on NYSE. Multiplied out, that is $58.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $59 million total recorded for the deal.
Zymeworks BC Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Zymeworks BC Inc.. This page is general information, not investment advice.